AI assistant
Sending…
AbCellera Biologics Inc. — Director's Dealing 2021
Dec 10, 2021
31942_dirs_2021-12-10_87f1d635-8e2e-4f89-abaf-a092ef0bf09e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbCellera Biologics Inc. (ABCL)
CIK: 0001703057
Period of Report: 2021-12-07
Reporting Person: Montalbano John S. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-27 | Share option (right to buy) | $17.58 | A | 34282 | Acquired | 2031-08-27 | Common Shares (34282) | Direct |
| 2021-12-07 | Share option (right to buy) | $14.55 | A | 45532 | Acquired | 2031-12-07 | Common Shares (45532) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 26000 | Direct |
| Common Shares | 5000 | Indirect |
More from AbCellera Biologics Inc.
Board/Management Information
2026
Jun 5
Interim / Quarterly Report
2026
May 11
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 24
Earnings Release
2026
Feb 24
Regulatory Filings
2026
Jan 14